RNASEL

Across TCGA pan-cancer cohorts, RNASEL Mutation is linked to patient survival in 7 of 34 cancer types, making it a survival-associated RNASEL data layer compared with 26 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNASEL Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated RNASEL expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, LUSC, and BLCA are the cancer types where RNASEL Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.973	0.611	.002	24	view →
LUSC	OS	Median	III,IV	0.126	0.691	<.001	18	view →
BLCA	OS	Median	IV	0.074	0.599	<.001	15	view →
SARC	OS	Median	All	0.126	0.860	<.001	12	view →
SKCM	OS	Median	III,IV	0.212	0.729	<.001	8	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
LGG	OS	Median	All	0.307	0.811	.008	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNASEL–UCEC (DFS)

Open the UCEC breakdown →